The TRIUMPH program includes multiple phase 3 trials, and one trial, TRIUMPH-Outcomes, is specifically designed to answer the question of whether retatrutide reduces major adverse cardiovascular events
The MHRA has issued warnings about unregulated sources of GLP-1 medications, particularly given recent supply shortages
Our weight loss program in Fremont, California uses GLP-1 medications including Ozempic, Mounjaro, Wegovy, Zepbound, and more to help patients lose weight and reach their goals under the guidance of a licensed provider
The FDA allows compounding pharmacies to produce copies of drugs that are on the FDAs official drug shortages list
Getting a Personalized Tapering Plan Your healthcare provider will design a tapering plan specifically for you, factoring in your medical history, current dosage, personal goals, and even insurance requirements
Autophagy in Its (Proper) Context: Molecular Basis, Biological Relevance, Pharmacological Modulation, and Lifestyle Medicine